Article
Future of Therapy for Inborn Errors of Immunity
12 Jan 2022
Abstract excerpt
Over the past 20 years, the rapid evolution in the diagnosis and treatment of primary immunodeficiencies (PI) and the recognition of immune dysregulation as a feature in some have prompted the use of "inborn errors of immunity" (IEI) as a more encompassing term used to describe these disorders [1, 2] . This article aims to review the future of therapy of PI/IEI (referred to IEI throughout this paper)....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
